MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference
by
Bilsky EJ, Reid LD.
Department of Psychology,
Rensselaer Polytechnic Institute,
Troy, NY 12180.
Pharmacol Biochem Behav 1991 Jun;39(2):509-12

ABSTRACT

Methylenedioxymethamphetamine (MDMA) has previously been shown to produce a positive conditioned place preference (CPP) among rats. Here the effects of doses of a specific 5-HT3 antagonist, MDL72222, on MDMA's ability to produce a CPP were assessed. A dose of MDL72222 (0.03 mg/kg) blocked the establishment of a MDMA CPP. These results support the suggestions that compounds affecting the 5-HT3 receptor may be of particular interest in studying the pharmacology of self-administered drugs.

5-HT1b
5-HT1a
5-HT2c
History
MDMA/MDE
Controversies
Protect and survive
Ecstasy and tryptophan
Ecstasy and serotonin synthesis
Ecstasy and the serotonin receptors